Boston, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in digital healthcare enablement, today announced that SilverCloud® by Amwell earned three international healthcare honors. SilverCloud is a global digital mental health platform that provides 24/7 access to content and training for patients with mild to moderate symptoms of depression, anxiety and stress.
SilverCloud was honored at events celebrating excellence and achievement in digital health:
More than 12,000 people in Ireland have used SilverCloud’s guided iCBT content and training for mental health support and care. Of those with moderate to severe ranges of anxiety and depression, 54% showed reliable improvement in their symptoms through their use of the platform. SilverCloud has a 94% satisfaction rate among users.
“It’s an honor to be recognized for our important work with the HSE, which leverages our digital behavioral health solutions to ensure people across Ireland can access the mental health care and support they need,” said Derek Richards, SilverCloud head of research. “These three awards acknowledge the importance and viability of virtual care when it comes to providing mental health support. We’re proud to celebrate these outstanding achievements and health outcomes with our valued partner, the HSE.”
About Amwell
Amwell is a leading hybrid care, delivery enablement platform in the United States and globally, connecting and enabling providers, insurers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that hybrid care delivery will transform healthcare. We offer a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. With nearly two decades of experience, Amwell powers the digital care of more than 55 health plans, which collectively represent more than 90 million covered lives, and many of the nation’s largest health systems, representing over 2,000 hospitals. For more information, please visit https://business.amwell.com.
About SilverCloud by Amwell
The SilverCloud® by Amwell® offering provides 24/7 access to digital mental health and therapeutic care. The platform is a result of 20 years of research and partners with the NHS and leading academic institutions to develop clinically validated programs that span the spectrum of mental health needs. Learn more: www.silvercloudhealth.com.
©2023 American Well Corporation. All rights reserved. Amwell®, SilverCloud®, ConvergeTM, CarepointTM and the Amwell Logo are registered trademarks or trademarks of American Well Corporation.
Notice of Ownership
All materials contained herein are the property of American Well Corporation and are copyrighted under United States law and applicable international copyright laws and treaty provisions. The materials contained herein are not work product or "work for hire" on behalf of any third party. The materials contained herein constitute the confidential information of American Well Corporation, except for specific data elements provided by third parties, which are the confidential information of such third parties. The content contained herein results from the application of American Well proprietary processes, analytical frameworks, algorithms, business methods, solution construction aids and templates, all of which are and remain the property of American Well Corporation.
Trademark Notice
All of the trademarks, service marks and logos displayed on these materials (the "Trademark(s)") are registered and unregistered trademarks of American Well Corporation or third parties who have licensed their Trademarks to American Well Corporation. Except as expressly stated in these terms and conditions, you may not reproduce, display or otherwise use any Trademark without first obtaining American Well Corporation's written permission.
Last Trade: | US$7.59 |
Daily Change: | 0.15 2.02 |
Daily Volume: | 13,266 |
Market Cap: | US$103.760M |
December 18, 2024 October 30, 2024 October 08, 2024 July 31, 2024 |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREAstria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB